Administrative Core - Novel Therapeutics for FSHD
Administrative Core - Novel Therapeutics for FSHD
批准号:
10400189
负责人:
CHARLES P. EMERSON
金额:
$10.49万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-10 至 2024-05-31
关键词:
AdministratorAdvisory CommitteesBiomaterials ResearchBostonBusinessesCell LineChildClinicalClinical ManagementCollaborationsCommunicationCommunitiesCommunity OutreachContractsCore FacilityDevelopmentEnvironmentFacioscapulohumeral Muscular DystrophyFeedbackFundingGoalsHuman ResourcesIndustryInstitutionInternationalInternetLeadershipMassachusettsMissionMuscle CellsMuscular DystrophiesPathogenesisPatientsPoliciesProceduresRecordsReportingResearchResearch PersonnelResearch Project GrantsResearch TrainingResource SharingResourcesScheduleScientistSocietiesTrainingTraining and EducationUnited States National Institutes of HealthUniversitiesWorkcell repositorydata sharingdrug developmentexperienceindustry partnermedical schoolsmeetingsnovel therapeuticsoutreachpatient advocacy grouppatient outreachprogramssymposiumweb siteworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The Administrative Core A will be responsible for the planning, development, coordination, and overall
administration of the University of Massachusetts Medical School (UMMS) W ellstone MD CRC focused on
Facioscapulohumeral Muscular Dystrophy (FSHD). Center leadership will continue under Dr. Charles
Emerson at UMMS, Dr. Louis Kunkel at Children's Boston, and Kathryn Wagner at Kennedy Krieger, all
highly experienced research administrators and accomplished scientists. The administrative unit for Core A
will be located at UMMS, which has substantial resources, personnel and experience for management of a
P50 Center. Core A will be the administrative hub to manage all Center resources and communications and
carry out policies and procedures that establish an energized environment to enable effective communication
and collaboration among all the Center constituents, including investigators, trainees, FSHD patients and
advocacy groups, industry partners, NIH and the public. The Center will promote its mission through its
website, which disseminates information on Center activities, biomaterials and research, and through its
partnership with patient advocacy groups, particularly the FSH Society, which co-sponsors FSHD Research
W orkshops and Researcher-Patient Networking meetings to engage patients, researchers, trainees and NIH
in our Center mission. Through Core A, the Center will promote the distribution of muscle cell lines from its
W ellstone FSHD Cell Repository as a unique FSHD bio-resource. Internal committees will enable Center
leadership, investigators and trainees to effectively utilize resources, organize internal dataflow and
communications, and receive feedback on Center management, research progress and training. Regularly-
scheduled web conference meetings will focus on trainee and PI data sharing and research planning, and an
annual W ellstone Center Retreat at UMMS will bring investigators and trainees face-to-face with a Center
Advisory Committee (CAC) and NIH program leaders to review research progress, set goals and align Center
activities with the NIH W ellstone Center Network.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONTROL OF MUSCLE PROTEIN SYNTHESIS DURING MYOGENESIS
-
批准号:8051021
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2010
-
负责人:CHARLES P. EMERSON
-
依托单位:
Identification of inhibitors of hedgehog autoprocessing
-
批准号:8089846
-
项目类别:
-
资助金额:$5.08万
-
财政年份:2009
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:7932575
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2009
-
负责人:CHARLES P. EMERSON
-
依托单位:
CONTROL OF MUSCLE PROTEIN SYNTHESIS DURING MYOGENESIS
-
批准号:7867022
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2009
-
负责人:CHARLES P. EMERSON
-
依托单位:
Administrative Core - Novel Therapeutics for FSHD
-
批准号:10197167
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:8881247
-
项目类别:
-
资助金额:$139.25万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:8661472
-
项目类别:
-
资助金额:$108.62万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
FSHD Pre-clinical Development
-
批准号:10197171
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel Therapeutics for FSHD - Resources Core - Core C
-
批准号:10197168
-
项目类别:
-
资助金额:$39.56万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Training Core [Parent Title: NOVEL THERAPEUTICS FOR FSHD]
-
批准号:10197172
-
项目类别:
-
资助金额:$12.92万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:8336877
-
项目类别:
-
资助金额:$65.11万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:8141268
-
项目类别:
-
资助金额:$176.61万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
FSHD Genetic Modifiers
-
批准号:10197169
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
FSHD Genetic Modifiers
-
批准号:10400191
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel Therapeutics for FSHD
-
批准号:10400188
-
项目类别:
-
资助金额:$154.14万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Biomarkers for Therapy of FSHD (U54)
-
批准号:7917477
-
项目类别:
-
资助金额:$173.19万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel Therapeutics for FSHD
-
批准号:10197166
-
项目类别:
-
资助金额:$154.14万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel Therapeutics for FSHD - Resources Core - Core C
-
批准号:10400190
-
项目类别:
-
资助金额:$39.84万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
FSHD Drug Discovery
-
批准号:10400192
-
项目类别:
-
资助金额:$29.05万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
Novel therapeutics for FSHD
-
批准号:10879926
-
项目类别:
-
资助金额:$74.69万
-
财政年份:2008
-
负责人:CHARLES P. EMERSON
-
依托单位:
海外基金